Cargando…
Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
One hundred and eight patients with squamous cell carcinoma of the upper aerodigestive tract (UADT) (T3, T4, NO-N3; 17% stage II, 54% stage III, 27% stage IV) were given three courses of chemotherapy before any local treatment. The regimen consisted of cis-platinum 100 mg m-2 on day 1 and 5-fluorour...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001551/ https://www.ncbi.nlm.nih.gov/pubmed/3801272 |
_version_ | 1782135627797495808 |
---|---|
author | Thyss, A. Schneider, M. Santini, J. Caldani, C. Vallicioni, J. Chauvel, P. Demard, F. |
author_facet | Thyss, A. Schneider, M. Santini, J. Caldani, C. Vallicioni, J. Chauvel, P. Demard, F. |
author_sort | Thyss, A. |
collection | PubMed |
description | One hundred and eight patients with squamous cell carcinoma of the upper aerodigestive tract (UADT) (T3, T4, NO-N3; 17% stage II, 54% stage III, 27% stage IV) were given three courses of chemotherapy before any local treatment. The regimen consisted of cis-platinum 100 mg m-2 on day 1 and 5-fluorouracil 1000 mg m-2 on days 2-6; drugs were administered by continuous infusion. The toxicity of this protocol was acceptable, as 82% of the patients were able to receive the initially scheduled drug dose. The overall response rate of 86.5% included a 35% rate of complete lesion regression. The effect of this regimen on primary tumours was especially remarkable--87.5% responses, including 47.5% complete responses. Results for lymph node metastases were not as good--66% responses, including 33% complete responses. The best results were obtained for tumours of the oropharynx and hypopharynx; oral cavity lesions were the most refractory. For those patients who were subsequently operated on, histological examination of the surgical specimen either confirmed sterilization or demonstrated the persistence of small disease foci. After local treatment, which consisted of radiotherapy alone for 69% of patients, the lesion control rate was 80%. At 18 months follow-up, the survival rate for patients who achieved a complete response with chemotherapy was significantly better than that for patients with a response of less than 50%. |
format | Text |
id | pubmed-2001551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1986 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20015512009-09-10 Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Thyss, A. Schneider, M. Santini, J. Caldani, C. Vallicioni, J. Chauvel, P. Demard, F. Br J Cancer Research Article One hundred and eight patients with squamous cell carcinoma of the upper aerodigestive tract (UADT) (T3, T4, NO-N3; 17% stage II, 54% stage III, 27% stage IV) were given three courses of chemotherapy before any local treatment. The regimen consisted of cis-platinum 100 mg m-2 on day 1 and 5-fluorouracil 1000 mg m-2 on days 2-6; drugs were administered by continuous infusion. The toxicity of this protocol was acceptable, as 82% of the patients were able to receive the initially scheduled drug dose. The overall response rate of 86.5% included a 35% rate of complete lesion regression. The effect of this regimen on primary tumours was especially remarkable--87.5% responses, including 47.5% complete responses. Results for lymph node metastases were not as good--66% responses, including 33% complete responses. The best results were obtained for tumours of the oropharynx and hypopharynx; oral cavity lesions were the most refractory. For those patients who were subsequently operated on, histological examination of the surgical specimen either confirmed sterilization or demonstrated the persistence of small disease foci. After local treatment, which consisted of radiotherapy alone for 69% of patients, the lesion control rate was 80%. At 18 months follow-up, the survival rate for patients who achieved a complete response with chemotherapy was significantly better than that for patients with a response of less than 50%. Nature Publishing Group 1986-11 /pmc/articles/PMC2001551/ /pubmed/3801272 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Thyss, A. Schneider, M. Santini, J. Caldani, C. Vallicioni, J. Chauvel, P. Demard, F. Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
title | Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
title_full | Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
title_fullStr | Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
title_full_unstemmed | Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
title_short | Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
title_sort | induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001551/ https://www.ncbi.nlm.nih.gov/pubmed/3801272 |
work_keys_str_mv | AT thyssa inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck AT schneiderm inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck AT santinij inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck AT caldanic inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck AT vallicionij inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck AT chauvelp inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck AT demardf inductionchemotherapywithcisplatinumand5fluorouracilforsquamouscellcarcinomaoftheheadandneck |